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Abstract Conditioned medium from adipose
derived stem cells (ADSC-CM) stimulates both
collagen synthesis and migration of fibroblasts, and
accelerates wound healing in vivo. Recently, the
production and secretion of growth factors has been
identified as an essential function of adipose-derived
stem cells (ADSCs). However, the main soluble
factor of ADSC-CM which mediates paracrine effects
and its underlying mechanism has not been eluci-
dated yet. In this study, we considered transforming
growth factor-beta1 (TGF-b1) as a strong candidate
for paracrine effect of ADSC-CM and investigated
collagen synthesis and hyaluronic acid synthase
(HAS) expression. After ADSC-CM addition, colla-
gen type I, type III, HAS and hyaluronic acid (HA)
expressions on human dermal fibroblasts (HDFs)
were evaluated. Furthermore, to clarify effects of
TGF-b1 as a paracrine mediator, TGF-b1 antibody
and external supplementary TGF-b1 were treated to
HDFs. Collagens type I, type III, HAS-1 and HAS-2
mRNA expressions of HDFs were greatly increased
by ADSC-CM treatment, however there was no
change in TGF-b1 antibody treated HDFs compared
with non-treated control. These results strongly
demonstrate that TGF-b1 plays an important role as
a paracrine mediator of ECM synthesis. The fact that
TGF-b1 contained in ADSC-CM not only accelerates
collagen deposition but also increase hyaluronic
acid synthesis of HDFs through HAS-1 and HAS-2
expression was also elucidated in this study. There-
fore, ADSC-CM shows promise for the treatment
of cutaneous wounds and accelerates granulation
formation during healing process.
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Introduction
Since the existence of multipotent stem cells within
adipose tissue was reported in 1964, it has been
documented that adipose tissue-derived stem cells
(ADSCs) act in a similar way with the bone marrow-
derived mesenchymal stem cells, including their
morphology, colony frequency, immune phenotype
and surface markers (Kern et al. 2006). However, due
to the abundance, practicality and accessibility in the
human body, interest has rapidly grown in the plasticity
and therapeutic potential of ADSCs (Zhu et al. 2008).
Moreover, the production and secretion of various
extracellular matrix (ECM) components and cytokines
such as vascular endothelial growth factor (VEGF),
insulin-like growth factor (IGF), platelet derived
growth factor (PDGF), transforming growth factor-
beta (TGF-b) and fibroblast growth factor (FGF) from
ADSCs have been received extensive attention as
autologous inducing factors for tissue regeneration
(Kinnaird et al. 2004; Kratchmarova et al. 2002; Maeda
et al. 1996, 1997; Rehman et al. 2004).
ADSCs and their secretomes mediate diverse skin
regeneration processes, such as wound healing,
antioxidant protection, anti-wrinkle and hair-growth
effects (Kim et al. 2007; Park et al. 2008). Wound
healing effects of ADSCs were also reported with a
conditioned-medium of ADSCs (ADSC-CM) (Park
et al. 2010). In response to injury, ADSCs not only
directly migrate to the wound area, differentiate and
repopulate the wound with healthy skin appendages,
but also show paracrine activation of human dermal
fibroblasts (HDFs) and keratinocytes, resulting in
accelerating proliferation and synthesis of ECM
components on the wound site (Kim et al. 2009). In
a highly coordinated biological process of dermal
wound healing, by these syntheses and cell-to-cell,
cell-to-cytokine interdependencies, skin fibroblasts
repair wounds and maintain the integrity of skin as
well (David-Raoudi et al. 2008).
In spite of various approaches to demonstrate
availability of ADSC-CM, the underlying biology
related to the ECM production especially hyaluronic
acid (HA) has not been well elucidated. HA, a large-
molecular-weight glycosaminoglycan (GAG) which is
widely expressed in tissues remodeling, is known to
affect collagen synthesis and maturation via the HA
receptor-mediated signaling pathway (Allemann et al.
2001). In addition, HA plays a critical role in various
biological events such as differentiation of the HDFs,
wound closure, anti-inflammatory response, cell pro-
liferation, differentiation, and GAG synthesis (Akmal
et al. 2005; Meran et al. 2007; Turino and Canor 2003;
Williams et al. 2003).
In an attempt to explore the contribution of ADSC-
CM to the cutaneous wound healing, we investigated
the underlying biology of HA and collagen produc-
tion mediated by ADSC-CM treatment onto HDFs.
Moreover, based on the fact that TGF-b stimulates
HA synthesis in HDFs, the paracrine mediator
released from ADSCs which determines mRNA and
protein expression profile was investigated.
Materials and methods
Cell cultures
Human Dermal Fibroblasts (HDFs) were purchased
from Modern Cell & Tissue Technologies (MCTT,
Seoul, Korea) and American Type Culture Collection
(ATCC, VA, USA) respectively. HDFs were cultured
in Dulbecco’s modified Eagle medium (DMEM,
WelGENE, Daegu, Korea) supplemented with 10%
FBS, penicillin (100 U/ml) and streptomycin
(100 lg/ml). The cells were maintained at 37 C in
a humidified atmosphere of 5% CO2 and 95% air and
the growth medium was changed every 3–4 days.
The cells were cultured with serum-free medium for
24 h before experiment.
Adipose-derived stem cells (ADSCs) were pur-
chased from Invitrogen (StemPro Human Adipose-
Derived Stem Cell Kit, Cat. No. R7788-110, CA,
USA). As per the user’s manual, ADSCs were isolated
from human lipoaspirate tissue and expanded for one
passage before cryopreservation. The ADSCs express
the following flow cytometry cell-surface protein
profile: positive CD29, CD44, CD73, CD90, CD105,
and CD166; negative CD14, CD31, CD45, and Lin1.
ADSCs were cultured in serum-free DMEM/F12
(WelGENE, Daegu, Korea) medium and no cellular
death was observed during the culture period.
Preparation and treatment of ADSC-CM
ADSCs (4 9 105 cells) of passage 3–5 were seeded
on a 100 mm dish and cultured with a serum free
medium for 72 h and the medium was then collected.
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The collected ADSC-CM was sterilized with 0.22 lm
syringe filter (Millex-GS Filter Unit, MA, USA)
after centrifugation at 300 9 g for 5 min.
Confluent HDFs were treated with serum-free
medium containing 5 ng/ml of TGF-b1 or 0 (control),
10, 50 and 100% concentration of ADSC-CM. TGF-
b1 in 10 mM citric acid (pH 3.0) was reconstituted
with 1 mg/ml of bovine serum albumin to activate
TGF-b1 from its latent form prior to use. After 4 h of
treatment, HDFs were processed for further total
RNA extraction to confirm the dose-effects of ADSC-
CM treatment. After 3, 12, 36, 48 h of treatment, the
culture medium supernatant was utilized for enzyme-
linked immunosorbent (ELISA) assay and HDFs
were processed for further total RNA extraction.
TGF-b1 blocking assay
To clarify the effects of the TGF-b1, the action of
TGF-b1 composed in ADSC-CM was neutralized
with a chicken anti-human TGF-b1 antibody
(Abcam, MA, USA). HDFs cultured in 6-well plates
were cultured with serum-free medium containing
0.1% BSA for starvation for 24 h prior to use.
5 ng/ml of TGF-b1 and 50% ADSC-CM were pre-
incubated with a chicken anti-human TGF-b1 anti-
body (100 ng/ml) for 1 h and added to the HDFs.
After 24 h, the cells were washed with cold PBS and
prepared for RT–PCR analysis.
Total RNA isolation and RT–PCR analysis
The total RNA from each sample was extracted using
easy-BLUETM Total RNA Extraction Kit (iNtRON
Biotech, Gyeonggi-Do, Korea). According to the
manufacturer’s instruction, 1 mg of total RNA was
used for reverse transcription reaction with the first-
strand cDNA synthesis mix containing 20 mM Tris–
HCl (pH 8.4), 50 mM KCl, 2.5 mM MgCl2, 10 mM
dithiothreitol, 0.25 mM of each dNTP, and 100 U of
Moloney murine leukemia virus reverse transcriptase.
The sequences of the sense (?) and antisense (-)
primer pairs of HAS-1, HAS-2, HAS-3, collagen type
I, collagen type III and control were as follows: HAS-1
(?) 50-ggtgcttctgtcgctctacg-30 and (-) 50-gctactgggtgg
ccatgttgac-30 (product size 306 bp); HAS-2 (?)
50-tggggcggcaagcgcgaggtcat gtacacagc-30 and (-)
50-ca ccagagcgcgttgtacagccactcacggaag-30 (product
size 250 bp); HAS-3 (?) 50-tggcctactttggctgtgtgcag-30
and (-) 50-agatcatctctgcattgccc-30 (product size
300 bp); and glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH) (?) 50-agccgcatcttcttttgcgtc-30 and (-)
50-tcatatttggcaggtttttct-30 (product size 580 bp).
Amplification of cDNA fragments was performed on
PCR through 30 cycles with 1 ll of each RT product as
a template DNA in a 60 mM Tris–HCl (pH 9.1) buffer
containing 18 mM (NH4)2SO4, 16 mM MgCl2,
0.25 mM of each dNTP, 0.1 nmol of each primer,
and iMax-Taq DNA polymerase. Each sample (5 ll) of
the final PCR product was separated using a 1%
agarose gel and visualized using UV fluorescence after
staining with ethidium bromide. Template control,
GAPDH, was included in each run. The intensity of the
bands was measured using the Quantity One Software
(Bio-Rad, CA, USA).
ELISA assay for protein expression
The concentrations of collagen and hyaluronic acid in
the culture medium aliquots were measured using
Hyaluronan Enzyme-Linked Immunosorbent Assay
Kit (HA-ELISA, Echelon Bioscience Incorporated,
UT, USA) and Human Collagen1 ELISA (COSMO
BIO CO., LTD, Tokyo, Japan) according to the
manufacturer’s instruction.
In brief, standards and samples were transferred into
the HA ELISA plate and treated with Working Enzyme.
Working substrates were used for further color devel-
opment. The amount of collagen secreted into culture
medium was assessed by pepsin digestion. Biotinylated
anti-collagen antibody and standard solutions or assay
samples were mixed well then transferred into 96 well
plates for following avidin-HRP conjugate solution
treatment. Routinely, the plates were incubated with the
substrate at 37 C for 1–2 h before reading the optical
density at 405 and 450 nm. Optical densities were
determined by using a microtiter plate spectrophotom-
eter. Two independent experiments were performed and
the blank reading was subtracted from the values for
both standards and samples. A standard curve was
created by plotting the logarithm of the mean absor-
bance of each standard versus the logarithm of the HA
and collagen concentration.
Statistical analysis
Data are expressed as mean ± standard error mean
(S.E.M.). Statistical significance was assessed using
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one-way analysis of variance (ANOVA) followed by
Bonferroni multiple comparisons test or Student
t-test. Statistical analysis was performed with the
GraphPad Prism package (GraphPad Software, CA,
USA). P values less than 0.05 were considered
statistically significant.
Results
HAS-1, HAS-2, collagen type I and collagen type
III mRNA expression level of HDFs
HDFs were treated with various concentrations of
ADSC-CM (0, 10, 50 and 100%) to investigate dose
effects of ADSC-CM on HAS-1, HAS-2, collagen type
I and collagen type III mRNA expression. HDFs
treated with 0, 10, 50, 100% of ADSC-CM for 4 h
showed dose-dependent increase in HAS-1 and HAS-2
mRNA expression as shown in the representative
picture of agarose gel of Fig. 1a. Relative mRNA
expression of HAS-1 and HAS-2 to GAPDH was
determinated and is also shown in Fig. 1a. HDFs
cultured with 100% ADSC-CM showed the highest
value in both HAS-1 and HAS-2 mRNA expression. A
dose-dependent increase in the HAS-1 and HAS-2
expression by ADSC-CM treatment was confirmed
although the amount of mRNA expression was gener-
ally higher in HAS-1.
As shown in the agarose gel picture in Fig. 1b,
treatment with ADSC-CM for 4 h increased expression
of both collagen type I and collagen type III mRNA
levels in a dose-dependent manner. Relative mRNA
expression of collagen type I and collagen type III to
GAPDH showed the highest value in 100% ADSC-CM
treated HDFs. Compared to the control (ADSC-CM
0%), a 1.5-fold of increase in collagen type I mRNA
were observed with 100% ADSC-CM treated HDFs.
Vertical (y) axes of the graph in Fig. 1 were assessed
as % of control (ADSC-CM 0%) with relative mRNA
expression values to the glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) expression.
Time-course effects of TGF-b1 and ADSC-CM on
collagen type I and type III synthesis and HAS
expression in HDFs
In order to confirm a dominant paracrine mediator
which determines HAS and collagen mRNA
expression profile, TGF-b1, one of the paracrine
factors present in ADSC-CM, was used to treat
HDFs. Then the time course effect of TGF-b1 was
compared with that of 50% ADSC-CM on HDFs.
The expression of HAS-1 mRNA was gradually
increased in the ADSC-CM and the TGF-b1 treated
groups. This increased expression was a dose depen-
dant and was sustained for about 50 h. However,
there was no change in HAS-1 mRNA expression
level of control group (ADSC-CM 0%) (Fig. 2).
Increased mRNA expression of HAS-2 was also
observed and the up-regulated peaks were detected
after 36 h of 50% ADSC-CM and 5 ng/ml TGF-b1
treatment. On the other hand, after 48 h of treatment
mRNA expression of HAS-2 showed slight decrease
both in ADSC-CM and TGF-b1 treated HDFs. There
was no change in HAS-2 mRNA expression level of
ADSC-CM 0% control (Fig. 2). In case of HAS-3,
there was no observable change in mRNA expression
in neither experimental groups nor control. The
increased expression of HAS-3 mRNA by ADSC-
CM and TGF-b1 treatment was not identified.
Collagen type I and collagen type III mRNA
expression also started to increase gradually after
treatment and the highest expression was observed
after 24 h in collagen type I and after 36 h in collagen
type III mRNA expression. After this up-regulation,
mRNA expression of collagen type I and collagen
type III were again down-regulated to basal level.
Although there was no change in mRNA expression
of control, expression profiles of collagen type I and
collagen type III observed to be similar in control
groups.
Although it is hard to confirm the difference in
mRNA expression level with naked eye, the pictures
of agarose gel obtained from RT–PCR are shown in
Fig. 2b. In TGF-b1 treated group, the pattern of
increasing and decreasing mRNA expression
appeared to be similar to the group treated with
50% ADSC-CM (Fig. 2b).
General expression level of mRNA appeared to be
different between the ADSC-CM and TGF-b1 treated
groups, however, the time points of the increase and
decrease, and expression profile were similar. This
similarity between 5 ng/ml TGF-b1 and 50% ADSC-
CM treated group in time-course effects implies
TGF-b1 to be a potent mediator among ADSC-CM
components which determines mRNA and protein
expression profiles of ECM.
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TGF-b1 blocking assay
Figure 3 shows similar increased expression patterns
in collagen and HAS expression between TGF-b1 and
ADSC-CM treated groups, and decreased expression
patterns in TGF-b1 and ADSC-CM treated groups
resulted from anti-human TGF-b1 antibody addition.
For this TGF-b1 blocking assay, TGF-b1 solution and
ADSC-CM were neutralized with TGF-b1 antibody
and used for the treatment of HDFs for 24 h, and we
observed increased expression in HAS-1, HAS-2,
collagen type I and collagen type III mRNA at the
time point of 24 h Fig. 2.
The concentration of the TGF-b1 antibody which
shows complete inhibition of TGF-b1 (0.25 ng/ml)
was indicated to be 5–10 ng/ml in the instructor’s
manual. The concentration of TGF-b1 antibody used
in this study (100 ng/ml) seems to be sufficient to
block the activity of TGF-b1 in both TGF-b1 solution
and ADSC-CM. The antibody treatment suppressed
increase of mRNA expression in HAS and collagen
by TGF-b1 and ADSC-CM treatment on HDFs. The
representative pictures of agarose gel obtained from
RT–PCR (Fig. 3a) show visible suppression in
HAS and collagen mRNA expression after TGF-b1
neutralization.
As shown in Fig. 3b, when HDFs were cultured
under TGF-b1 neutralized condition, the mRNA
expressions of HAS-1, HAS-2, collagen type I and
collagen type III showed no significant difference to
non-treated control even though cells were treated
with ADSC-CM or TGF-b1. Furthermore, the sup-
pressing activity of TGF-b1 antibody treatment
was most significant in collagen type III mRNA
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Fig. 1 Effect of ADSC-CM treatment on mRNA expression of
HAS and collagen in HDFs. (a) The agarose gels indicate
HAS-1 and HAS-2 mRNA expression (left) and the quantified
data of HAS-1 and HAS-2 mRNA expression relative to
GAPDH expression show dosedependent increase in mRNA
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expression. In general, the suppressive effects of
TGF-b1 antibody neutralization appeared to be
greater in collagen than HAS. As a result, the
increased collagen type I and type III mRNA
expression by 50% ADSC-CM and TGF-b1 treatment
were reversed to nontreated control level.
Time-course effects of TGF-b1 and ADSC-CM
on HA and collagen type I, type III synthesis
of HDFs
The actual HA and collagen type I protein expression
facilitated by mRNA up-regulation as a result of
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ADSC-CM or TGF-b1 treatment were confirmed
using ELISA.
HA protein was increased and up-regulated peak
was observed after 24 h of ADSC-CM and TGF-b1
treatment (Fig. 4). HA expression was induced in the
initial stage of ADSC-CM or TGF-b1 treatment
(Fig. 4). In addition, HA expression was facilitated
without HAS-3 mRNA up-regulation (Fig. 2a). HA
and collagen type I were gradually increased without
ADSC-CM or TGF-b1 treatment in non-treated
control owing to the nature of HDFs which synthesize
various kind of ECM. Collagen type I expression was
gradually increased for 48 h after ADSC-CM and
TGF-b1 treatment (Fig. 4). Although collagen type I
mRNA was most abundant after 24 h of treatment
then decreased (Fig. 2a), the collagen type I protein
expression prolonged for 48 h after treatment
(Fig. 4). Whereas the concentration of TGF-b1 in
ADSC-CM was confirmed to be 103 pg/ml and we
only used 50% of ADSC-CM in this experiment, the
amount of collagen type 1 was similar to that of
HDFs treated with 5 ng/ml TGF-b1. The existence of
other factors which support the activity of TGF-b1
can be implied with this result.
Discussion
In the present study, paracrine effects of ADSC-CM
on HDFs were demonstrated with dose-dependent
increased mRNA expression levels of HAS-1, HAS-
2, collagen type I and collagen type III and further
HA and collagen type I expression. In addition, we
showed that mRNA and protein expression profile of
HDFs which was induced by ADSC-CM treatment
was similar to that induced by external TGF-b1
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Fig. 3 HAS-1, HAS-2, collagen type I, and type III mRNA
expression profile in HDFs after treatment with ADSCCM or
TGF-b1 with or without neutralization with anti-TGF-b1
antibody. (a) Representative pictures of agarose gels showing
mRNA expression obtained using RTPCR. (b) Quantified
mRNA expression relative to GAPDH mRNA expression.
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treatment. HA, one of the major ECM components is
responsible for skin moisture and collagen type I and
type III play a pivotal role in maintaining skin
elasticity. These findings are closely related to wound
healing mediated by ADSC-CM as previously
reported (Turino and Canor 2003).
HA is synthesized on the inner surface of the
plasma membrane by three different isoenzymes,
HAS-1, HAS-2 and HAS-3. Each isoform is capable
of synthesizing HA molecules of a given size and
exhibits different kinetic properties plus different
cell-type characteristics (Itano et al. 1999). It has
been reported that many cytokines are able to
modulate HAS transcription in cell cultures. Data
obtained for the treatment of fibroblasts with trans-
forming nuclear factor-alpha (TNF-a) and TGF-b1
showed a significant increase in mRNA expression
and protein synthesis of HAS-1 and HAS-2, key
enzymes for high-molecular-weight HA. Recently,
the possibility of high-molecular-weight HA to
protect stressed cells has been implied and it is also
considered to be related to in vivo antioxidant effects
of ADSCs (Campo et al. 2006). ADSC-CM which
was used in this study increased mRNA expression of
HAS-1 and HAS-2 that are closely related to high-
molecular-weight HA production.
Although the role of HA in wound healing has
been clarified with various research (David-Raoudi
et al. 2008; Guo et al. 2010; Larson et al. 2010), the
specialized role of HAS-1, HAS-2 and HAS-3 has not
yet been elucidated. HA accumulation during wound
healing process is known to be induced by TGF-b1
which facilitates up-regulation of HAS-2 (Guo et al.
2010). It has been known for a long time that HA is
abundant in the early granulation tissue of dermal
wounds, and associates with scar-less healing (Larson
et al. 2010). Recently it was reported that the
wounding-induced up-regulation of HA synthesis is
not limited to mesenchymal cells, but is also very
prominent in the epithelium. The discovery that
epidermal injury up-regulates the expression of HAS-
2 and HAS-3 in keratinocytes and causes a sixfold
increase of epidermal HA was reported by Tammi
et al. (2005) . HAS-2 and HAS-3 are considered to be
especially related to the initial state of wound
healing, and therefore mediate cell migration. How-
ever, it is hard to determine which one is more
relevant to wound healing.
HA accumulation has been shown to enhance the
TGF-b1 driven differentiation of HDFs to myofibro-
blasts and the effects of TGF-b1 on proliferation
(Meran et al. 2007, 2008). In precise, TGF-b1
dependant differentiation of fibroblasts is antagonized
by inhibition of HAS, confirming that the TGF-b1
driven differentiation of fibroblasts is a major source
of myofibroblasts, and that HA is a major modulation
of this process (Webber et al. 2009). Myofibroblasts
are specialized cells which exist in granulation tissue
and mediate the closure of wounds and formation of
collagen (Kim et al. 2008). In this study, ADSC-CM
treatment to HDFs resulted in similar mRNA and
protein expression profiles with those of the HDFs
which exhibit the TGF-b1 dependant myofibroblastic
responses. Increase in collagen synthesis which might
result from myofibroblastic responses of HDFs was
also confirmed by ADSC-CM treatment. This finding
implies TGF-b1 be a potent mediator of HA synthesis
which determines mRNA and protein expression
profiles among ADSC-CM constituents. Without
presuming the involvement of myofibroblastic differ-
entiation, TGF-b1 is known as a potent factor
accelerates wound healing by stimulating collagen
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deposition and HA accumulation (Puolakkainen et al.
1995) and seems to played an important role in ECM
synthesis as a major component of ADSC-CM.
Whereas the amount of TGF-b1 (approx. 103 pg/ml)
in ADSC-CM was miniscule compared with the
concentration of independently added TGF-b1 (5 ng/ml),
there was no significant difference in HAS-1, HAS-2,
collagen type I and collagen type III mRNA expres-
sion. Moreover, the amount of HA synthesized after
ADSC-CM treatment was larger than after TGF-b1
treatment. With these results, it can be implied that
growth factors or cytokines in ADSC-CM amplified
ECM synthesis is induced by TGF-b1. ADSC-CM
treatment can be an efficient way of treatment to
augment ECM in the tissue.
Recently, several studies have reported the various
pharmacological effects of ADSC-CM in wound
healing and photoaging via activation of dermal
fibroblasts (Kim et al. 2007; Planat-Benard et al.
2004). However, underlying mechanism has not been
fully characterized and few studies focus on under-
lying biology of soluble factors composed in ADSC-
CM. Especially involvement of HAS isoforms to
activation of ADSC-CM treated fibroblasts has not
yet been reported. We confirmed paracrine effects of
ADSC resulted in up-regulation of HA through
increased expression of HAS-1 and HAS-2 mRNA.
The main mediator of these paracrine effects present
in ADSC-CM was elucidated by introducing TGF-b1
and TGF-b1 antibody. TGF-b1 is assumed to be a
potent mediator that modulates paracrine effects of
ADSC-CM. However, to clarify the mechanisms of
synergistic effects and the direct role of TGF-b1
within ADSC-CM, signal transduction of TGF-b1
and other cytokines present in ADSC-CM which are
involved in ECM synthesis should be studied in
further wound healing research. Moreover, myofib-
roblastic differentiation and phenotypic change in
fibroblasts which is induced by ADSC-CM treatment
is currently under investigation in our research group.
In conclusion, we confirmed the paracrine effects
of ADSC-CM on HDFs which activate collagen
synthesis and HA accumulation. The production of
collagen and HA is known to be mediated by several
cytokines; however TGF-b1 was implied to play a
pivotal role in increasing mRNA expression and to
impact further HA and collagen expression profile.
Moreover, our study suggests the usefulness of
ADSC-CM as a wound healing agent.
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